Works matching IS 00178748 AND DT 2021 AND VI 61 AND IP 4
Results: 18
Paroxysmal hemifacial pain: A report of two cases.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 4, p. 683, doi. 10.1111/head.14104
- By:
- Publication type:
- Article
Barriers to care in episodic and chronic migraine: Results from the Chronic Migraine Epidemiology and Outcomes Study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 4, p. 628, doi. 10.1111/head.14103
- By:
- Publication type:
- Article
Developmental innervation of cranial dura mater and migraine headache: A narrative literature review.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 4, p. 569, doi. 10.1111/head.14102
- By:
- Publication type:
- Article
Erenumab for migraine prevention in a patient with mitochondrial encephalopathy, lactate acidosis, and stroke‐like episodes syndrome: A case report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
A link between gastrointestinal disorders and migraine: Insights into the gut–brain connection.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 4, p. 576, doi. 10.1111/head.14099
- By:
- Publication type:
- Article
Functional difficulties mediate the association between exposure to adverse childhood experiences and headaches among children: Findings from a population‐based study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 4, p. 673, doi. 10.1111/head.14098
- By:
- Publication type:
- Article
Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 4, p. 662, doi. 10.1111/head.14097
- By:
- Publication type:
- Article
Long‐term efficacy and safety during open‐label erenumab treatment in Japanese patients with episodic migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 4, p. 653, doi. 10.1111/head.14096
- By:
- Publication type:
- Article
Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene‒related peptide‐targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug–drug interaction study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 4, p. 642, doi. 10.1111/head.14095
- By:
- Publication type:
- Article
Quantitative arterial spin labeling magnetic resonance imaging analysis of reversible cerebral vasoconstriction syndrome: A case series.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 4, p. 687, doi. 10.1111/head.14094
- By:
- Publication type:
- Article
Updated process for American Headache Society Guidelines.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Comparing treatments in the emergency department: What works for migraine?
- Published in:
- 2021
- By:
- Publication type:
- Editorial
A prospective, randomized, double‐blind trial of intravenous chlorpromazine versus intravenous prochlorperazine for the treatment of acute migraine in adults presenting to the emergency department.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 4, p. 603, doi. 10.1111/head.14091
- By:
- Publication type:
- Article
Virtual issue: Kids (with headache disorders) are not just little adults (with headache disorders).
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 4, p. 563, doi. 10.1111/head.14090
- By:
- Publication type:
- Article
The association between inflammatory bowel disease and migraine or severe headache among US adults: Findings from the National Health Interview Survey, 2015‐2016.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 4, p. 612, doi. 10.1111/head.14087
- By:
- Publication type:
- Article
Erenumab patient characteristics, medication adherence, and treatment patterns in the United States.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 4, p. 590, doi. 10.1111/head.14068
- By:
- Publication type:
- Article
Real‐world efficacy, tolerability, and safety of ubrogepant.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 4, p. 620, doi. 10.1111/head.14062
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 4, p. 1, doi. 10.1111/head.13871
- Publication type:
- Article